FCMI
IMGN

Foresite Capital Management III’s Immunogen Inc IMGN Stock Holding History

Foresite Capital Management III’s Portfolio IMGN Stock Details IMGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q2 		– Sell
-42,815
Closed -$365K – 23
2016
Q1 		$365K Hold
42,815
– – 0.28% 23
2015
Q4 		$581K Buy
+42,815
New +$527K 0.52% 19

Other funds holding IMGN

ClearBridge Investments
ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

Foresite Capital Management III's IMGN Position: Q2 2016 in Review

Foresite Capital Management III sold out of Immunogen Inc (IMGN) in Q2 2016, closing a stake of 42,815 shares — an estimated $365K sold.

Foresite Capital Management III first reported a position in IMGN in Q4 2015 and held it in 2 quarters. The position peaked at $581K in Q4 2015. 158 funds tracked by Wall St. Rank hold IMGN as of Q2 2016.

  • Foresite Capital Management III reported no remaining Immunogen Inc position as of Q2 2016 after selling out during the quarter.
  • Foresite Capital Management III sold 42,815 Immunogen Inc shares in Q2 2016, an estimated $365K.
  • Foresite Capital Management III first reported a position in Immunogen Inc in Q4 2015 and held it in 2 quarters.
  • Foresite Capital Management III's Immunogen Inc position peaked at $581K in Q4 2015.
  • 158 funds tracked by Wall St. Rank held Immunogen Inc as of Q2 2016.

Based on Foresite Capital Management III's 13F filing for Q2 2016, filed 12 Aug 2016.